首页> 外国专利> HUMANIZED T CELL MEDIATED IMMUNE RESPONSES IN NON-HUMAN ANIMALS.

HUMANIZED T CELL MEDIATED IMMUNE RESPONSES IN NON-HUMAN ANIMALS.

机译:非人类动物中人化T细胞介导的免疫反应。

摘要

Disclosed herein are non-human animals (e.g., rodents, e.g., mice or rats) genetically engineered to express a humanized T cell co-receptor (e.g., humanized CD4 and/or CD8 (e.g., CD8a and/or CD8ß )), a human or humanized T cell receptor (TCR) comprising a variable domain encoded by at least one human TCR variable region gene segment and/or a human or humanized major histocompatibility complex that binds the humanized T cell co-receptor (e.g., human or humanized MHC II (e.g., MHC II a and/or MHC II ß chains) and/or MHC I (e.g., MHC I a ) respectively, and optionally human or humanized ß2 microglobulin). Also provided are embryos, tissues, and cells expressing the same. Methods for making a genetically engineered animal that expresses at least one humanized T cell co-receptor (e.g., humanized CD4 and/or CD8), at least one humanized MHC that associates with the humanized T cell co-receptor (e.g., humanized MHC II and/or MHC I, respectively) and/or the humanized TCR are also provided. Methods for using the genetically engineered animals that mount a substantially humanized T cell immune response for developing human therapeutics are also provided.
机译:本文公开了经基因工程改造以表达人源化T细胞共受体(例如人源化CD4和/或CD8(例如CD8a和/或CD8β))的非人类动物(例如啮齿动物,例如小鼠或大鼠),人或人源化T细胞受体(TCR),其包含由至少一个人源TCR可变区基因片段编码的可变域和/或与人源化T细胞共受体结合的人源化或人源化主要组织相容性复合物(例如人源化或人源化MHC II(例如,MHC II a和/或MHC IIß链)和/或MHC I(例如MHC I a),以及任选的人或人源化ß2微球蛋白。还提供了表达它们的胚胎,组织和细胞。制备表达至少一种人源化T细胞共受体(例如,人源化CD4和/或CD8),至少一种与人源化T细胞共受体结合的人源化MHC(例如,人源化MHC II)的基因工程动物的方法和/或分别为MHC I)和/或人源化TCR。还提供了使用具有基本人源化的T细胞免疫应答的基因工程动物来开发人类疗法的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号